Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes

被引:1
|
作者
Eskola, V
Vähäsalo, P
Åkerblom, HK
Knip, M
机构
[1] Univ Helsinki, Hosp Children & Adolscents, FIN-00029 Helsinki, Finland
[2] Tampere Univ, Sch Med, FIN-33101 Tampere, Finland
[3] Tampere Univ Hosp, Dept Paediat, Tampere, Finland
[4] Oulu Univ, Dept Paediat, Oulu, Finland
关键词
type; 1; diabetes; gender; first-degree relatives; islet cell antibodies; prediction; type 1 diabetes mellitus;
D O I
10.1159/000069327
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To assess the relation between islet cell antibody (ICA) positivity and demographic characteristics in an extensive series of first-degree relatives of children with type 1 diabetes (T1D). Methods: Family members of children diagnosed with T1D before the age of 16 years and attending one of 27 participating paediatric units in Finland taking care of children with diabetes were invited to volunteer for an ICA screening program aimed at identifying individuals eligible for inclusion in the European Nicotinamide Diabetes Intervention Trial (ENDIT). The final series comprised 2,522 first-degree relatives (1,107 males) with a mean age of 20.4 (range 0.1-51.9) years, out of whom 390 were fathers, 622 mothers, 717 brothers, and 793 sisters of affected cases. Results: Two hundred and four family members (8.1%) tested positive for ICA with levels ranging from 3 to 564 (median 18) Juvenile Diabetes Foundation (JDF) units. One hundred and five relatives (4.2%) had an ICA level of 18 JDF units or more. Males had detectable ICA more often than females (9.6 vs. 6.9%; p = 0.02). Antibody-positive family members under the age of 20 years had higher ICA levels than the older ones [median 18 (range 3-514) JDF units vs. 10 (range 3-564) JDF units; p = 0.0081. Among the adult relatives ( :20 years of age) anti body-positive females had higher ICA levels than the males [median 10 (range 5-564) JDF units vs. 9 (range 3-130) JDF units; p = 0.04]. Siblings had an increased frequency of high-titre ICA ( greater than or equal to 18 JDF units) when compared to the parents (4.8 vs. 3.2%; p = 0.05). Among siblings, we found a higher frequency of ICA positivity in brothers than in sisters (10.8 vs. 6.9%; p = 0.01), and this was also true for high-titre ICA (6.0 vs. 3.8%; p = 0.04). Geographically, the highest ICA prevalence was seen among relatives living in the middle of Finland (10.4 vs. 7.2% in the other parts of Finland; p = 0.01). Conclusions: These results imply that male gender and young age favour positive ICA reactivity among family members of children with T1D. Siblings test positive for high ICA titres ( greater than or equal to 18 JDF units) more frequently than parents. Accordingly, judged from demographic characteristics, the yield of ICA screening in first-degree relatives would be maximized by targeting young brothers of affected cases. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 50 条
  • [31] Biomarkers of islet beta cell stress and death in type 1 diabetes
    Sims, Emily K.
    Evans-Molina, Carmella
    Tersey, Sarah A.
    Eizirik, Decio L.
    Mirmira, Raghavendra G.
    DIABETOLOGIA, 2018, 61 (11) : 2259 - 2265
  • [32] RELATIONSHIP BETWEEN URINARY NEOPTERIN EXCRETION AND ISLET CELL ANTIBODIES IN TYPE-1 (INSULIN-DEPENDENT) DIABETES
    MANNA, R
    SALVATORE, M
    DILEO, MAS
    SCUDERI, F
    GRECO, AV
    GHIRLANDA, G
    GAMBASSI, G
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1991, 17 (01): : 33 - 36
  • [33] Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk
    Nucci, Anita M.
    Virtanen, Suvi M.
    Cuthbertson, David
    Ludvigsson, Johnny
    Einberg, Ulle
    Huot, Celine
    Castano, Luis
    Aschemeier, Baerbel
    Becker, Dorothy J.
    Knip, Mikael
    Krischer, Jeffrey P.
    DIABETOLOGIA, 2021, 64 (04) : 826 - 835
  • [34] Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
    Ng, Kenney
    Anand, Vibha
    Stavropoulos, Harry
    Veijola, Riitta
    Toppari, Jorma
    Maziarz, Marlena
    Lundgren, Markus
    Waugh, Kathy
    Frohnert, Brigitte, I
    Martin, Frank
    Lou, Olivia
    Hagopian, William
    Achenbach, Peter
    DIABETOLOGIA, 2023, 66 (01) : 93 - 104
  • [35] ISLET AUTOANTIBODIES AND RESIDUAL BETA-CELL FUNCTION IN CHILDREN WITH TYPE 1 DIABETES DEPENDING ON AGE OF MANIFESTATION
    Romanenkova, Elizaveta M.
    Zufarova, Iulduz M.
    Sorokin, Daniil Y.
    Eremina, Irina A.
    Sechko, Elena A.
    V. Nikankina, Larisa
    Peterkova, Valentina A.
    Bezlepkina, Olga B.
    Laptev, Dmitry N.
    DIABETES MELLITUS, 2023, 26 (03): : 204 - 212
  • [36] Infant Feeding in Relation to the Risk of Advanced Islet Autoimmunity and Type 1 Diabetes in Children With Increased Genetic Susceptibility: A Cohort Study
    Hakola, Leena
    Takkinen, Hanna-Mari
    Niinisto, Sari
    Ahonen, Suvi
    Nevalainen, Jaakko
    Veijola, Riitta
    Ilonen, Jorma
    Toppari, Jorma
    Knip, Mikael
    Virtanen, Suvi M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2018, 187 (01) : 34 - 44
  • [37] HETEROGENEITY OF ISLET-CELL CYTOPLASMIC ANTIBODIES AND AUTOANTIBODIES TO GLUTAMATE-DECARBOXYLASE IN RELATIVES OF PATIENTS WITH TYPE-1 (INSULIN-DEPENDENT) DIABETES
    BERGEROT, I
    SOUCHIER, C
    THIVOLET, C
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1993, 316 (11): : 1368 - 1373
  • [38] Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic
    Zeller, Ivo
    Weiss, Andreas
    Arnolds, Stefanie
    Schuette-Borkovec, Katharina
    Arabi, Sari
    von dem Berge, Thekla
    Casteels, Kristina
    Hommel, Angela
    Kordonouri, Olga
    Larsson, Helena Elding
    Lundgren, Markus
    Rochtus, Anne
    Snape, Matthew D.
    Szypowka, Agnieszka
    Vatish, Manu
    Winkler, Christiane
    Bonifacio, Ezio
    Ziegler, Anette-Gabriele
    INFECTION, 2024, 52 (06) : 2465 - 2473
  • [39] Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment
    Cabrera-Rode, E
    Perich, P
    Diaz-Horta, O
    Tiberti, C
    Molina, G
    Arranz, C
    Martin, JM
    Licea, M
    De Leiva, A
    Puig-Domingo, M
    Dimario, U
    AUTOIMMUNITY, 2002, 35 (07) : 469 - 474
  • [40] Islet Cell Therapy and Stem Cell Therapy for Type 1 Diabetes: There Will Always Be a Hope
    Hatipoglu, Betul A.
    Blanchette, Julia
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) : 187 - 193